Drug discovery is traditionally slow and costly, taking over 14 years and $2.6 billion on average to bring a new drug to market. But AI is reshaping the process. Using gene-expression-driven models, AI can predict promising drug candidates much earlier, cutting down failed attempts and speeding up development. By 2025, AI is expected to drive up to 30% of new drug discoveries and reduce timelines by up to 40%, slashing costs by nearly 30%. Early successes show promise against tough diseases like

Drug Discovery Science